IP Library Granted Patent US 8,101,367
Granted Patent B2
US 8,101,367 · App. 12/592,373 · Granted Jan 24, 2012

Antibodies specific to antigens of

Assignee: Medical Diagnostic Laboratories, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,367
App. No.
12/592,373
Granted
Jan 24, 2012
Kind
B2
Abstract

Disclosed are antibodies that bind to the antigenic proteins GroES, RpIL, GroEL, SodB, UbiG, the ABC transporter, and an expressed antigenic protein of unknown function (the “BepA” protein) of Bartonella henselae , and use of these antigenic proteins in immunoassays in order to determine whether a sample from a subject contains one or more of these antibodies. Presence of such an antibody in the subject indicates that the subject is or was infected with Bartonella henselae , or indicates that the subject has an increased likelihood of being infected presently or in the past with Bartonella henselae . Also disclosed are kits for performing immunoassays, wherein each kit contains one or more of these antigenic proteins and also contains the reagents necessary for conducting an immunoassay.

Claims (24)

1. A method for determining whether a subject contains an antibody in sera against Bartonella henselae , comprising the steps of:

(a) providing an isolated antigen produced by Bartonella henselae , said isolated antigen is selected from the group consisting of UbiG and ABC Transporter;

(b) providing a sample from a subject;

(c) conducting an immunoassay on said sample utilizing said isolated antigen, wherein said immunoassay detects the presence of antibodies that recognize said isolated antigen; and

(d) determining that the subject contains an antibody against said isolated antigen if the results of the immunoassay indicate that an antibody that recognizes said isolated antigen is present in said sample.

2. The method of claim 1 , wherein said immunoassay is an immunofluorescence assay (IFA).

3. The method of claim 1 , wherein said immunoassay is an enzyme-linked immunosorbent assay (ELISA).

4. The method of claim 1 , wherein said immunoassay is a Western blot.

5. The method of claim 1 , wherein said isolated antigen is a recombinant protein.

6. A kit, comprising:

(a) an isolated antigen produced by Bartonella henselae , said isolated antigen is selected from the group consisting of UbiG and ABC Transporter; and

(b) reagents necessary for conducting an immunoassay, wherein the immunoassay is capable of detecting the presence of an antibody in a sample, and wherein the antibody is capable of binding to said isolated antigen.

7. The kit of claim 6 , wherein said immunoassay is an immunofluorescence assay (IFA).

8. The kit of claim 6 , wherein said immunoassay is an enzyme-linked immunosorbent assay (ELISA).

9. The kit of claim 6 , wherein said immunoassay is a Western blot.

10. The kit of claim 6 , wherein said isolated antigen is a recombinant protein.

11. An enzyme-linked immunosorbent assay (ELISA) for determining whether a subject contains an antibody in sera against Bartonella henselae , comprising the steps of:

(a) coating a surface with an isolated antigen produced by Bartonella henselae , wherein said isolated antigen is selected from the group consisting of GroES, RpIL, BepA, and GroEL;

(b) adding to said coated surface sera from a subject under conditions whereby antibody present in said sera binds to said isolated antigen; and

(c) detecting said bound antibody,

wherein the presence of said bound antibody is indicative that said subject contains an antibody in sera against Bartonella henselae , and wherein said ELISA has a sensitivity of at least 78%.

12. The method of claim 11 , wherein said surface is a microtiter plate.

13. The method of claim 11 , wherein said detecting step is performed by using a goat anti-human IgG-HRP antibody, and 3, 3′, 5, 5′-tetramethylbenzidine.

14. The method of claim 11 , wherein said isolated antigen is a recombinant protein.

Assignments (4)
SECURITY INTEREST Recorded Jul 13, 2022
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 060638/0353 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
SECURITY INTEREST Recorded Apr 27, 2018
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 046031/0381 →
SECURITY INTEREST Recorded Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
Continuity (4)
Continuation 12075036 · Mar 7, 2008
Division 11418409 · May 3, 2006
Provisional Application 60684707 · May 26, 2005
Related Publication 20100298155A1 · Nov 25, 2010